{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:23:25Z","timestamp":1790166205573,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Wuhan Scientific Research Fund","award":["WX16B11"],"award-info":[{"award-number":["WX16B11"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bbrc.2016.08.047","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T07:50:36Z","timestamp":1470815436000},"page":"893-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk\/Mnk1\/eIF4E pathway"],"prefix":"10.1016","volume":"478","author":[{"given":"Zhong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.08.047_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.08.047_bib2","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2016.08.047_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","article-title":"How i treat CML blast crisis","volume":"120","author":"Hehlmann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2016.08.047_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.08.047_bib5","first-page":"265","article-title":"Diagnosis and treatment of intestinal helminths. I. Common intestinal cestodes","volume":"1","author":"Tanowitz","year":"1993","journal-title":"Gastroenterologist"},{"key":"10.1016\/j.bbrc.2016.08.047_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/2211016a0","article-title":"Mechanism of action of reagents that uncouple oxidative phosphorylation","volume":"221","author":"Weinbach","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.08.047_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2014.04.005","article-title":"Inhibition of Wnt\/beta-catenin pathway by niclosamide: a therapeutic target for ovarian cancer","volume":"134","author":"Arend","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2016.08.047_bib8","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-10-3978","article-title":"Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations","volume":"71","author":"Osada","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.08.047_bib9","doi-asserted-by":"crossref","first-page":"e29290","DOI":"10.1371\/journal.pone.0029290","article-title":"Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/beta-catenin pathway","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.08.047_bib10","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/bcj.2011.38","article-title":"Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production","volume":"1","author":"Khanim","year":"2011","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bbrc.2016.08.047_bib11","article-title":"Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2016.08.047_bib12","article-title":"Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer","author":"Liu","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbrc.2016.08.047_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1042\/BCJ20160121","article-title":"Niclosamide blocks glucagon phosphorylation of Ser552 on beta-catenin in primary rat hepatocytes via PKA signalling","volume":"473","author":"Chowdhury","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2016.08.047_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2015.06.120","article-title":"Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes","volume":"464","author":"Xiang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.08.047_bib15","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-09-3950","article-title":"Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.08.047_bib16","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","article-title":"Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation","volume":"99","author":"Holtz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2016.08.047_bib17","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/1535-7163.MCT-07-2357","article-title":"eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling","volume":"7","author":"Soni","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2016.08.047_bib18","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1182\/blood-2003-07-2193","article-title":"Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells","volume":"103","author":"Kharas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2016.08.047_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00011-015-0801-5","article-title":"Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"64","author":"Liang","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbrc.2016.08.047_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cellimm.2013.12.006","article-title":"Antihelminthic niclosamide modulates dendritic cells activation and function","volume":"288","author":"Wu","year":"2014","journal-title":"Cell. Immunol."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.bbrc.2016.08.047_bib21","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1038\/sj.thj.6200449","article-title":"Switching off oncogenic signals in chronic myeloid leukaemia","volume":"5","author":"Melo","year":"2004","journal-title":"Hematol. J."},{"key":"10.1016\/j.bbrc.2016.08.047_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/BJ20141066","article-title":"The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E\/CYFIP1 binding","volume":"467","author":"Beggs","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2016.08.047_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.08.047_bib24","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2016.08.047_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2016.08.047_bib26","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2016.08.047_bib27","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbrc.2016.08.047_bib28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/bjc.2014.259","article-title":"Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells","volume":"111","author":"Takeishi","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2016.08.047_bib29","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.2004","article-title":"Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development","volume":"24","author":"Ueda","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2016.08.047_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13572","article-title":"eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies","volume":"513","author":"Boussemart","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.08.047_bib31","doi-asserted-by":"crossref","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","article-title":"Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function","volume":"110","author":"Lim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.08.047_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2009-02-205153","article-title":"Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin","volume":"114","author":"Assouline","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2016.08.047_bib33","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-11-0430","article-title":"A\u00a0phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer","volume":"17","author":"Hong","year":"2011","journal-title":"Clin. Cancer Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1631302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1631302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T07:04:49Z","timestamp":1568271889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1631302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0006291X1631302X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.047","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk\/Mnk1\/eIF4E pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}